Clinical Trial Update: Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bryostatin-1 in metastatic kidney cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Bryostatin-1 (bryostatin-1)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED